✦ LIBER ✦

Zaprinast, a type V phosphodiesterase inhibitor, dilates capacitance vessels in anaesthetised rats

✍ Scribed by Sylvia S.W Ng; Catherine C.Y Pang

Book ID: 114016341
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 142 KB
Volume: 351
Category: Article
ISSN: 0014-2999
DOI: 10.1016/s0014-2999(98)00319-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zaprinast, a phosphodiesterase type-5 in

Zaprinast, a phosphodiesterase type-5 inhibitor, alters paced mating behavior in female rats

✍ Ann S. Clark; Sarah H. Meerts; Fay A. Guarraci 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 333 KB

Chronic treatment of DA-8159, a new phos

Chronic treatment of DA-8159, a new phosphodiesterase type V inhibitor, attenuates endothelial dysfunction in stroke-prone spontaneously hypertensive rat

✍ Seul Min Choi; Jee Eun Kim; Kyung Koo Kang 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Subacute toxicities and toxicokinetics o

Subacute toxicities and toxicokinetics of DA-8159, a new phosphodiesterase type V inhibitor, after single and 4-Week repeated oral administration in rats

✍ Hyun J. Shim; Yu C. Kim; Ji M. Jang; Kyung J. Park; Dong H. Kim; Kyung K. Kang; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

## Abstract The subacute toxicities (10 male and 10 female rats at each dose) and the toxicokinetics (5 male rats at each dose) of DA‐8159, a new phosphodiesterase type V (PDE V) inhibitor, were evaluated after single (at day 1) and 4‐week (at day 28) oral administration of the drug at doses of 0 (

A selective type V phosphodiesterase inh

A selective type V phosphodiesterase inhibitor, E4021, protects the development of right ventricular overload and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension

✍ Takashi Takahashi; Tsugiyasu Kanda; Masahiro Inoue; Tadashi Suzuki; Isao Kobayas 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 596 KB